A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide

Changhyun Roh
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p2173
Academic Journal
No abstract available.


Related Articles

  • Genome-Wide Analysis of Protein-Protein Interactions and Involvement of Viral Proteins in SARS-CoV Replication. Ji'An Pan; Xiaoxue Peng; Yajing Gao; Zhilin Li; Xiaolu Lu; Yingzhao Chen; Ishaq, Musarat; Dan Liu; DeDiego, Marta L.; Enjuanes, Luis; Deyin Guo // PLoS ONE;2008, Vol. 3 Issue 10, p1 

    Analyses of viral protein-protein interactions are an important step to understand viral protein functions and their underlying molecular mechanisms. In this study, we adopted a mammalian two-hybrid system to screen the genome-wide intraviral protein-protein interactions of SARS coronavirus...

  • Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systems. Jin-Yan Chen; Wan-Nan Chen; Poon, Kwok-Man Vincent; Bo-Jian Zheng; Xu Lin; Yong-Xiang Wang; Yu-Mei Wen // Archives of Virology;Mar2009, Vol. 154 Issue 3, p507 

    To reveal the putative cellular factors involved in SARS coronavirus replication, the helicase (Hel, nsp13) of SARS coronavirus was used to screen the cDNA library of rat pulmonary epithelial cells using the yeast two-hybrid system. Positively interacting proteins were further tested using a...

  • Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Ahn, Dae-Gyun; Choi, Jin-Kyu; Taylor, Deborah; Oh, Jong-Won // Archives of Virology;Nov2012, Vol. 157 Issue 11, p2095 

    The severe acute respiratory syndrome coronavirus (SARS-CoV) RNA genome is replicated by a virus-encoded RNA replicase, the key component of which is the nonstructural protein 12 (nsp12). In this report, we describe the biochemical properties of a full-length recombinant SARS-CoV nsp12...

  • A Facile Inhibitor Screening of Hepatitis C Virus NS3 Protein Using Nanoparticle-Based RNA. Changhyun Roh // Biosensors (2079-6374);Dec2012, Vol. 2 Issue 4, p427 

    Globally, over hundreds of million people are infected with the hepatitis C virus: the global rate of death as a direct result of the hepatitis C virus has increased remarkably. For this reason, the development of efficient drug treatments for the biological effects of the hepatitis C virus is...

  • Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs. Tan, Emily L.C.; Eng Eong Ooi, Emily L.C.; Chin-Yo Lin; Hwee Cheng Tan, Emily L.C.; Ai Ee Ling; Lim, Bing; Stanton, Lawrence W. // Emerging Infectious Diseases;Apr2004, Vol. 10 Issue 4, p581 

    Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection. In this study, we investigated whether a panel of commercially available antiviral drugs exhibit in vitro...

  • A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design. Sharmin, Refat; Islam, Abul Bashar // BMC Bioinformatics;2014, Vol. 15 Issue 1, p1 

    Background Coronaviruses are the diverse group of RNA virus. From 1960, six strains of human coronaviruses have emerged that includes SARS-CoV and the recent infection by deadly MERS-CoV which is now going to cause another outbreak. Prevention of these viruses is urgent and a universal vaccine...

  • Establishment of a Serological Panel for In Vitro Diagnostics of Severe Acute Respiratory Syndrome. Wang, Der-Yuan; Wang, Kun-Teng; Wang, Ying-Ching; Weng, Shu-Ching; Chang, Wei-Hao; Shih, Daniel Yang-Chih // Journal of Food & Drug Analysis;Dec2012, Vol. 20 Issue 4, p938 

    Severe acute respiratory syndrome (SARS) is an infectious disease with a high mortality rate. Because SARS suddenly disappeared after an approximately 1-year-long pandemic period (November 2002 to July 2003), insufficient data was available for the development of in vitro diagnostics for SARS...

  • Targeting Immunity, Not Invader, Key To Broad-Spectrum Antiviral. Breindl, Anette // BioWorld Today;6/26/2007, Vol. 18 Issue 123, p1 

    The article reports on the development of broad-spectrum antibiotics that target immunity and specific viral proteins. Author Robert Silverman and various researchers report on compounds that have broad-spectrum activity against RNA viruses, which make up at least two-thirds of all viruses,...

  • Identification of a new human coronavirus. van der Hoek, Lia; Pyrc, Krzysztof; Jebbink, Maarten F.; Vermeulen-Oost, Wilma; Berkhout, Ron J. M.; Wolthers, Katja C.; Wertheim-van Dillen, Pauline M. E.; Kaandorp, Jos; Spaargaren, Joke; Berkhout, Ben // Nature Medicine;Apr2004, Vol. 10 Issue 4, p368 

    Three human coronaviruses are known to exist: human coronavirus 229E (HCoV-229E), HCoV-OC43 and severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). Here we report the identification of a fourth human coronavirus, HCoV-NL63, using a new method of virus discovery. The virus...

  • Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum. Chen, S.; Lu, D.; Zhang, M.; Che, J.; Yin, Z.; Zhang, S.; Zhang, W.; Bo, X.; Ding, Y.; Wang, S. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2005, Vol. 24 Issue 8, p549 

    The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics